CELU's logo.
Ticker Symbol: CELU

Celularity Inc - Class A

$7.20 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001752828

Company Profile

Celularity, Inc. headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (NK) cells, genetically-modified NK cells, T-cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. In addition, Celularity develops and manufactures innovative biomaterials also derived from the postpartum placenta. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 170 Park Avenue
CEO: Robert Joseph Hariri
Tags: N/A

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.23
Change: -$0.01 ( -5.41%)
Days Range: $0.23 - $0.25
Beta: 1.83
52wk. High: $2.46
52wk. Low: $0.19
Ytd. Change -86.06%
50 Day Moving Average: $0.26
200 Day Moving Average: $0.47
Shares Outstanding: 190948190

Valuation

Market Cap: 4.5B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A